biosimilars

News
Remaining Challenges, Potential Solutions for the Regulatory Evaluation of Biosimilars
12/16/2020
A recent article outlines challenges that remain regarding the regulatory evaluation of biosimilars and offers potential solutions for the future.
A recent article outlines challenges that remain regarding the regulatory evaluation of biosimilars and offers potential solutions for the future.
A recent article outlines...
12/16/2020
Journal of Clinical Pathways
News
Policy Review on Improving Oncology Biosimilar Launches
12/11/2020
A recent policy review identifies factors that prevent the effective launch of oncology biosimilars.
A recent policy review identifies factors that prevent the effective launch of oncology biosimilars.
A recent policy review...
12/11/2020
Journal of Clinical Pathways
News
ACP Recommendations for Improving Market Competition
09/21/2020
A position paper released by the American College of Physicians made concrete policy reform suggestions for prescription drug competition, calling for a realignment of incentives and rewards for true innovation.
A position paper released by the American College of Physicians made concrete policy reform suggestions for prescription drug competition, calling for a realignment of incentives and rewards for true innovation.
A position paper released by the...
09/21/2020
Journal of Clinical Pathways
News
Oncologist Perception of Efficacy, Safety, and Willingness to Prescribe Biosimilars
06/26/2020
Researchers from CVS Health assessed the expected biosimilar prescribing behaviors of practicing oncologists for originator products bevacizumab, trastuzumab, rituximab, and pegfilgrastim. Biosimilars are a...
Researchers from CVS Health assessed the expected biosimilar prescribing behaviors of practicing oncologists for originator products bevacizumab, trastuzumab, rituximab, and pegfilgrastim. Biosimilars are a...
...
06/26/2020
Journal of Clinical Pathways
News
Cost Savings With Biosimilar in Prophylaxis of Chemo-Induced Febrile Neutropenia
06/19/2020
Researchers from the University of Arizona Cancer Center conducted simulation modeling of cost savings from conversion of pegfilgrastim to biosimilar pegfilgrastim-cbqv for the prophylaxis of chemotherapy-induced...
Researchers from the University of Arizona Cancer Center conducted simulation modeling of cost savings from conversion of pegfilgrastim to biosimilar pegfilgrastim-cbqv for the prophylaxis of chemotherapy-induced...
...
06/19/2020
Journal of Clinical Pathways
Research Reports
Implications of Manufacturer Contracting: A Quantitative Model to Assess Biosimilar Market Feasibility
10/15/2018
Abstract: Eight years have passed since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) of 2010. Since then, 12 biosimilars have received approval from the Food and Drug Administration,...
Abstract: Eight years have passed since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) of 2010. Since then, 12 biosimilars have received approval from the Food and Drug Administration,...
...
10/15/2018
Journal of Clinical Pathways
Research Reports
Community Oncologists` Perception and Acceptance of Biosimilars in Oncology
09/13/2018
Abstract: Biosimilars are hypothesized to contribute to lowering health care costs by entering the market at a discounted price compared with their reference biologics. Until recently, only filgrastim biosimilars...
Abstract: Biosimilars are hypothesized to contribute to lowering health care costs by entering the market at a discounted price compared with their reference biologics. Until recently, only filgrastim biosimilars...
...
09/13/2018
Journal of Clinical Pathways

Upcoming Events

Advances in Inflammatory Bowel Disease Regionals
April 5 ⁠–⁠ April 6
Rx summit logo
April 21 ⁠–⁠ April 24
April 29 ⁠–⁠ April 30
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
Psych Congress Regionals
May 1 ⁠–⁠ May 2
May 7 ⁠–⁠ May 9
NEI Congress
May 8 ⁠–⁠ May 10
Dermatology Week
May 14 ⁠–⁠ May 16
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
May 28 ⁠–⁠ May 31
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use